Concepedia

William R. Grove

WR

Statistics

Publications

21

Citations

907

H-Index

15

Active since

1921

Affiliations

Pfizer (United States)(Current)

The University of Texas MD Anderson Cancer Center

National Cancer Institute

Cancer Research Center

University of Maryland, Baltimore

William R. Grove is an author at Pfizer (United States) specializing in pharmacology, medicine, and oncology.

Publications per year

1921–2006

21

Publications

21

Peripheral Tuberculous Lymphadenitis

Andrea Polesky, William R. Grove · Medicine · 2005 · 166 citations

, , +13

Phase I Study of Oral CI-994 in Combination with Carboplatin and Paclitaxel in the Treatment of Patients with Advanced Solid Tumors

L. Pauer, Jairo Olivares, Casey Cunningham et al. · Cancer Investigation · 2004 · 108 citations

, , +16

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study

David Richards, Kristi A. Boehm, David Waterhouse et al. · Annals of Oncology · 2006 · 100 citations · Full text

, , +7

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure

Mark M. Applefeld, Kathryn A. Newman, William R. Grove et al. · The American Journal of Cardiology · 1983 · 84 citations

, , +8

Outpatient dobutamine and dopamine infusions in the management of chronic heart failure: Clinical experience in 21 patients

Mark M. Applefeld, Kathryn A. Newman, Frederick J. Sutton et al. · American Heart Journal · 1987 · 81 citations

, , +9

1–5 of 21